HEXADECENE
1-hexadecene is an unbranched sixteen-carbon alkene with one double bond between C-1 and C-2.
製品には実際どれくらい入っているか
この成分の含有量を表示した製品はまだありません。
この成分を含む製品のうち28件は全成分の前の方(1%ラインより前)、67件は後ろ(ふつう1%以下)に書いています。
この成分を含む製品
確認済み 95件中 12件 · 十分に入っている製品から · 全 95件を見る
AROMATICATea Tree Purifying Shampoo 400ml
MURRENAll Day Moisture Balancing Cleansing Gel
TOSOWOONGFast Boosting Protein Shampoo
KIOSKINKIOSKIN Midinoxide Anti Hair Loss Shampoo
SOME BY MISOME BY MI Yuja Niacin Brightening All-in-One Cleanser 100ml
Derma:BDaily Moisture Foaming Hand Wash 500ml
I'm FromI'm From Mugwort Gel Cleanser
MEDIPEELMEDIPEEL Melanon X Ampoule Cleanser 150ml
DASHUDASHU Daily Herbal Scalp Gold Shampoo EX
DASHUDASHU Daily Herbal Scalp Gold Shampoo EX 500ml (Scalp Strengthening / Hair Loss Relief)
SOOOSwim Body Wash
HEYBRORooted Body Wash Balancing
定義
米国FDA 物質登録 · UNII 38H8547VP0 · 登録名 HEXADECENE (MIXED ISOMERS) · 混合物
1-hexadecene is an unbranched sixteen-carbon alkene with one double bond between C-1 and C-2.
出典: PubChem
化粧品での役割
安全性・規制情報
韓国の有害物質GHS分類なし · 既存化学物質
Other restriction: ban substances that deplete the ozone layer
出典: EU CosIng 成分リスト
詳しい資料 — 表示名・識別番号・物性・試験記録・文献
公式表示名・定義
日本化粧品工業会の表示名称 ヘキサデセン: 本品は、次の化学式で表される不飽和炭化水素である。
出典: 日本化粧品工業会 表示名称
別名・識別情報
- CAS No.化学物質登録番号
- 26952-14-7
- EC No.EU化学物質目録番号
- 248-131-4
- DTXSID米国EPA化学物質番号
- DTXSID90912325
製品が実際に使っている用途
米国EPAにこの成分を届け出た製品11件の用途です。化粧品以外の製品も含まれるため、上の数行がこの成分の主な使い道といえます。
- Viscosity modifier2
- Surfactant (surface active agent)2
- Solvent2
- Sizing agent1
- Lubricating agent1
- Plating agent1
- Processing aids not otherwise specified1
- Fuel1
出典: 米国EPA CompTox
刺激・感作試験の記録
皮膚試験16件・眼試験4件の記録があります。
試験ごとに結論が分かれています(最も多い結論の割合 15%)。この成分が刺激性だとは言い切れないということです。 原料そのものを試験した記録で、完成品に含まれる濃度での刺激性とは異なります。
試験20件をすべて見る
- Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) OPPTS 870.2500 according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
出典: 米国EPA CompTox
関連文献
- An endophytic Fusarium sp. isolated from Monarda citriodora produces the industrially important plant-like volatile organic compound hexanal. · 2017
- GCMS analysis and antimicrobial action of latex of Euphorbia caducifolia · 2012
- Contact cheilitis from bisabolol and polyvinylpyrrolidone/hexadecene copolymer in lipstick · 2008
- Peeling cosmetic method using the 8-hexadecene-1,16-dicarboxylic acid · 2005
- Cosmetic peeling method using the 8-hexadecene-1,16-dicarboxylic acid · 2005